RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES
Kelly, K.M., Daw, S., Mauz‐Körholz, C., Mascarin, M., Michel, G., Cooper, S., Beishuizen, A., Leger, K.J., Garaventa, A., Buffardi, S., Brugières, L., Harker‐Murray, P., Cole, P.D., Drachtman, R.A., Manley, T., Francis, S., Sacchi, M., Leblanc, T.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
S822 NIVOLUMAB AND BRENTUXIMAB VEDOTIN‐BASED, RESPONSE‐ADAPTED TREATMENT IN PRIMARY REFRACTORY AND IN PEDIATRIC PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA IN CHECKMATE 744
Leblanc, T., Harker‐Murray, P., Mauz‐Körholz, C., Mascarin, M., Michel, G., Cooper, S., Beishuizen, A., Leger, K.J., Garaventa, A., Buffardi, S., Brugières, L., Kelly, K.M., Cole, P.D., Drachtman, R.A., Manley, T., Francis, S., Sacchi, M., Daw, S.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article